Grifols

Quality and efficiency are a reflection of the talent and dedication of everyone who is part of our organization. Matthew Quigley, incoming quality control in Dublin, Ireland, plays a key role ensuring plasma quality for manufacturing essential plasma-derived medicines. For him, teamwork and a strong sense of collaboration are fundamental to achieving excellence. We invite you to watch the video to hear more from Matthew about his experience and what drives him every day. #GrifolsTeam

On World Humanitarian Day, we reaffirm our commitment to global solidarity and to ensuring access to essential treatments in the most critical situations. Over the past year, our teams across the globe have actively responded to emergencies ― from flood relief efforts in Brazil and Spain to aid during hurricanes and wildfires in the U.S. ― mobilizing resources and people to bring essential help where it’s needed most. Through long-standing partnerships with organizations like Direct Relief and the World Federation of Hemophilia, we work every day to ensure uninterrupted access to vital medicines in times of crisis and to improve healthcare in vulnerable communities worldwide. Humanitarian aid is built on ongoing commitment, collaboration, and concrete action. Together, we can make a difference. #WorldHumanitarianDay

For decades, opening and emptying plasma containers was a manual process, one that exposed workers to low temperatures or sharp instruments and also risked contamination of the plasma unit. Recognizing the need for a safer, more efficient solution, Grifols developed ABO® and PBO® in the early 2000s, two automated systems that open bottles and bags of frozen plasma, transforming plasma fractionation. By automating the processes of opening and emptying the containers, through plasma thawing and robotic handling, these innovations protect product integrity and worker safety while enhancing efficiency. Today, leading pharmaceutical companies rely on this cutting-edge technology. Automation isn’t just about efficiency—it’s about safety. Learn more 👉 http://spkl.io/6045AJAwH

🩸 Every drop counts. Our achievements are only possible because of the selfless gestures of those who chose to donate blood or plasma. This generosity helps people who need it the most. Thank you #GrifolsTeam for your commitment to making a difference. #BloodDonation #WeAreGrifols

Since 1990, Grifols Chile has been working to improve patient health through innovation, quality and trusted partnerships. Today, we celebrate 35 years of growth, progress and collaboration with the Chilean healthcare system. Over the years, the affiliate has built a solid presence in Biopharma, Diagnostics and Healthcare Solutions – delivering essential medicines, leading blood typing and clinical diagnostics and pioneering pharmacy automation in Latin America. Today, we continue to advance on our purpose: delivering innovative, reliable, and high-quality healthcare solutions. Thank you to all who have been part of this 35-year journey. Here’s to what’s next! #WeAreGrifols

We are proud to announce that the 2025 ALTA Award winners are: 🔹Dr. Sara Gil Martín, from Instituto de Salud Carlos III in Madrid for her research on “Genetic susceptibility to liver or lung disease in AATD patients”. 🔹Dr. Lily Wu, from University of Cambridge in UK for her project “The cellular mechanisms of somatic rescue in alpha 1-antitrypsin associated liver disease”. At Grifols we are committed to research and innovation to make a difference in people's health. Through the Grifols Scientific Awards, the ALTA Awards annually support research by young investigators committed to the future of therapy for alpha-1 antitrypsin deficiency (AATD). Learn more 👉https://lnkd.in/enau5MC

Voluntary plasma donations make it possible to produce our medicines, which are improving the quality of life of many people. For this reason, plasma donation takes place in highly controlled, safe environments. We have a growing network of centers worldwide. It is in these centers where phlebotomists work. Their role is crucial in the plasma donation process. Today, we invite you to meet Eilleen Cassan, a phlebotomist at a donor center in Winnipeg, Canada. #WeAreGrifols #GrifolsTeam

Q2 2025 results supporting a strong H1 2025 performance. Our strong performance continued in the second quarter, driven by a clear focus on the execution of our Value Creation Plan, achieving a robust performance across the board in H1 2025: ✅ Increasing revenues by 7.0% cc to EUR 3,677m ✅ Growing EBITDA Adj. by 12.7% cc to EUR 876m ✅ Group net profit increased to EUR 177 million. ✅ Improving free cash flow by EUR 182m ✅ Reducing leverage to 4.2x These results reflect the commitment of the #GrifolsTeam to creating long-term value for our donors, patients, and stakeholders. Find more details: http://spkl.io/6046AH7EO Our CEO, Nacho Abia, shares key highlights.

👑 Queens of European Football Congratulations to England for their historic win at the UEFA Women’s Euro 2025! We also celebrate Spain for their remarkable journey to the final, showing courage, determination, and the spirit of true competitors, in a thrilling final in Basel. We were honored to present the Top Scorer trophy to Esther González, forward for the Spanish national team. Delivered by our Chief Communications and Reputation Officer, Montse Ribas, this award recognizes the outstanding performance and the impact of players on the pitch. ⚽ This is a historic moment for women’s football, and one we’re honored to have been part of. WEURO 2025 has delivered record-breaking attendance (650,000+ fans), global reach, and unprecedented visibility for women’s football. Now in our fourth year of partnership with UEFA, we’re proud to have helped professionalize the women’s game and inspire fans across Europe to dream big through sport. 💪 Our commitment to building a more equal and just society remains stronger than ever. #WEURO2025 #PurposeMatters #GrifolsSocialImpact

Learning, sharing and collaborating 💡  We hosted our German Biotest AG colleagues last week at our Clayton site - helping provide insights into our manufacturing and production processes.  Over the span of three days, the teams analyzed workstreams to help align the timing of production steps and increase efficiency. By ensuring that every part of the manufacturing process works smoothly, we can ensure that we achieve our goal: delivering more medicines to more people around the world.